Company profile
Ratio Therapeutics
The Partner of Choice for Next-Generation Radiopharmaceutical Precision Medicine
- Industry
- Biotechnology Research
- Employees
- 81
- Headquarters
- Boston, Massachusetts
- Founded
- 2021
- LinkedIn followers
- 10,819
- Office locations
- 1
Ratio Therapeutics company summary
Ratio Therapeutics is a company in the Biotechnology Research industry, headquartered in Boston, Massachusetts, founded in 2021. On LinkedIn the company has around 81 employees and 10,819 followers.
What technology does Ratio Therapeutics use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Ratio Therapeutics
A discovery through early clinical phase pharmaceutical company, Ratio Therapeutics employs a suite of innovative technologies to develop best-in-class targeted radiotherapeutics for the treatment of cancer. Ratio Therapeutics’ Trillium™ targeting scaffold combines pharmacokinetic modulation with best-in-class chelation technology to create proprietary small molecule targeting agents to attack a broad array of cancer targets. Our compounds accommodate imaging and therapeutic radioisotopes, ie "theranostics". The tunable nature of our platform combined with small-scale imaging trials in patients results in accelerated, de-risked compound selection.
Where is Ratio Therapeutics located?
Ratio Therapeutics lists 1 location.
Compare companies similar to Ratio Therapeutics
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Ratio Therapeutics ratiotx.com | Biotechnology Research | 81 | 2021 | Boston, Massachusetts |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Ratio Therapeutics
What does Ratio Therapeutics do?
A discovery through early clinical phase pharmaceutical company, Ratio Therapeutics employs a suite of innovative technologies to develop best-in-class targeted radiotherapeutics for the treatment of cancer. Ratio Therapeutics’ Trillium™ targeting scaffold combines pharmacokinetic modulation with best-in-class chelation technology to create proprietary small molecule targeting agents to attack a broad array of cancer targets. Our compounds accommodate imaging and therapeutic radioisotopes, ie "theranostics". The tunable nature of our platform combined with small-scale imaging trials in patients results in accelerated, de-risked compound selection.
How many employees does Ratio Therapeutics have?
Ratio Therapeutics has around 81 employees on LinkedIn.
Where is Ratio Therapeutics headquartered?
Ratio Therapeutics is headquartered in Boston, Massachusetts.
When was Ratio Therapeutics founded?
Ratio Therapeutics was founded in 2021.
Build a lead list from companies like Ratio Therapeutics
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.